MedTrace Logo

Neuropsychology of Financial Capacity

NCT05791006 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2023-03-30

No results posted yet for this study

Summary

The present project aims to investigate the financial capacity in patients diagnosed with Parkinson's Disease or parkinsonism, brain tumor (glioma or meningioma) and cerebrovascular lesion (stroke), in order to evaluate the presence and degree of impairment, and the role of some factors as potential predictors of financial incapacity.

The term 'financial capacity' means both operations relating, for example, to asset management or investing money, and activities of daily life such as shopping or using small sums of money; these activities are mediated by different cognitive functions, from numerical and arithmetic skills to decision making. Financial capacity is, in fact, an instrumental activity of daily life (i.e. Instrumental Activity Of Daily Living, I-ADL) whose impairment negatively affects the functional autonomy of the individual, so as to be subject to legal protection.

To assess financial capacity, the Numerical Activities of Daily Living - Financial (NADL-F; Arcara et al., 2017) will be administered, a battery of tests aimed at investigating both financial performance and financial competence according to the most recent neuropsychological models proposed in the literature.

Conditions

Interventions

BEHAVIORAL

Neuropsychological tests

Neuropsychological assessment with: * NADL-F * Frontal Assessment Battery (FAB) * functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) * Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients * Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients

Sponsors & Collaborators

  • Istituto Auxologico Italiano

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-04
Primary Completion
2024-11-30
Completion
2024-11-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05791006 on ClinicalTrials.gov